Author: <span>Elena Rostova</span>

Author: Elena Rostova

Elena Rostova is a science writer covering research institutions, policy, and international collaboration in the life sciences. She earned a master’s degree in science and technology policy from the University of Cambridge and has reported on academic publishing and open-data initiatives. Her work focuses on the institutional forces shaping microbiome research. She contributes coverage of research partnerships and the broader scientific landscape to BiomeSci.
Investigational

Scientists Map the Global Spread of a DNA-Damaging Gut Microbe

A genomic and metagenomic survey across 45 countries finds that one bacterial lineage, Escherichia marmotae, dominates global carriage of a DNA-damaging toxin gene cluster linked to colorectal tumor growth in lab models; based on the study's abstract only, full text not obtained.

Emerging

Your Gut Bacteria Have Been Tracking Human Migration for 100,000 Years

Deep genetic sequencing shows the Tsimane of Bolivia and the Hadza of Tanzania still share 1,231 gut microbial species despite tens of thousands of years of separation, with strain-level dating suggesting co-migration with early human populations out of Africa and into the Americas. Most of the shared species are missing from industrialized guts today.

Emerging

How Gut Bacteria May Shape Childhood Asthma Risk

A review in Frontiers in Immunology traces how an infant's gut bacteria can shape airway inflammation in childhood asthma, pulling together birth-cohort studies like PASTURE and CHILD with mouse mechanism studies.

Emerging

Why Gut Bacteria Still Can’t Be Proven to Cause Cancer

A Lancet Microbe perspective argues that most gut microbiome cancer links come from unreliable cross-sectional studies, and calls for more prospective cohorts that bank stool samples years before any cancer diagnosis to finally test causation.

Investigational

A Gut Bacteria Byproduct From Pomegranates Eases Heart Failure in Mice

A new Science Advances study found that urolithin A, a postbiotic your gut bacteria make from pomegranate and berry compounds, directly activates a heart-relaxation protein called PKGIα, improving cardiac function in mice with a hard-to-treat form of heart failure and in lab-grown human heart tissue. The findings are preclinical only, and whether your gut even produces urolithin A from pomegranates in the first place depends on which bacteria you host.